Delayed
Nasdaq Stockholm
03:03:51 16/07/2024 pm IST
|
5-day change
|
1st Jan Change
|
0.414
SEK
|
+2.99%
|
|
+4.55%
|
-20.69%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
84.55
|
627.9
|
765.9
|
184
|
64.85
|
43.59
|
-
|
-
|
Enterprise Value (EV)
1 |
61.32
|
503.5
|
613.6
|
133.5
|
33.16
|
40.59
|
55.59
|
-14.41
|
P/E ratio
|
-0.89
x
|
-10.1
x
|
-12.8
x
|
-1.76
x
|
-0.35
x
|
-0.73
x
|
-4.39
x
|
0.63
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
56.4
x
|
349
x
|
306
x
|
46.8
x
|
21.9
x
|
4.36
x
|
0.51
x
|
0.18
x
|
EV / Revenue
|
40.9
x
|
280
x
|
245
x
|
34
x
|
11.2
x
|
4.06
x
|
0.65
x
|
-0.06
x
|
EV / EBITDA
|
-0.91
x
|
-8.41
x
|
-8.22
x
|
-1.31
x
|
-0.35
x
|
-0.74
x
|
-5.05
x
|
-0.17
x
|
EV / FCF
|
-0.72
x
|
-8.11
x
|
-7.83
x
|
-1.22
x
|
-0.28
x
|
-0.77
x
|
-3.47
x
|
-0.2
x
|
FCF Yield
|
-139%
|
-12.3%
|
-12.8%
|
-81.8%
|
-358%
|
-131%
|
-28.8%
|
-493%
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
1.42
x
|
2.44
x
|
0.52
x
|
Nbr of stocks (in thousands)
|
15,953
|
32,907
|
26,411
|
37,552
|
99,303
|
99,303
|
-
|
-
|
Reference price
2 |
5.300
|
19.08
|
29.00
|
4.900
|
0.6530
|
0.4390
|
0.4390
|
0.4390
|
Announcement Date
|
26/02/20
|
25/02/21
|
23/02/22
|
03/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1.5
|
1.8
|
2.5
|
3.929
|
2.961
|
10
|
85
|
246
|
EBITDA
1 |
-67.6
|
-59.9
|
-74.6
|
-102.3
|
-93.77
|
-55
|
-11
|
87
|
EBIT
1 |
-70.9
|
-63.2
|
-83
|
-104.2
|
-99.09
|
-57
|
-13
|
85
|
Operating Margin
|
-4,726.93%
|
-3,511.33%
|
-3,319.88%
|
-2,650.85%
|
-3,346.37%
|
-570%
|
-15.29%
|
34.55%
|
Earnings before Tax (EBT)
1 |
-94.94
|
-61.88
|
-83.36
|
-103.9
|
-99.03
|
-55
|
-13
|
85
|
Net income
1 |
-95.15
|
-62.07
|
-83.47
|
-104.2
|
-100
|
-55
|
-13
|
66
|
Net margin
|
-6,343.6%
|
-3,448.44%
|
-3,338.84%
|
-2,652.81%
|
-3,378.52%
|
-550%
|
-15.29%
|
26.83%
|
EPS
2 |
-5.980
|
-1.890
|
-2.260
|
-2.790
|
-1.860
|
-0.6000
|
-0.1000
|
0.7000
|
Free Cash Flow
1 |
-85
|
-62.09
|
-78.4
|
-109.2
|
-118.8
|
-53
|
-16
|
71
|
FCF margin
|
-5,666.47%
|
-3,449.44%
|
-3,136.2%
|
-2,778.77%
|
-4,013.51%
|
-530%
|
-18.82%
|
28.86%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
81.61%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
107.58%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/02/20
|
25/02/21
|
23/02/22
|
03/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
12
|
-
|
Net Cash position
1 |
23.2
|
124
|
152
|
50.5
|
31.7
|
3
|
-
|
58
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-1.091
x
|
-
|
Free Cash Flow
1 |
-85
|
-62.1
|
-78.4
|
-109
|
-119
|
-53
|
-16
|
71
|
ROE (net income / shareholders' equity)
|
-
|
-61.1%
|
-61.6%
|
-96.4%
|
-173%
|
-
|
-
|
129%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.3100
|
0.1800
|
0.8500
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
4.64
|
2.26
|
1.71
|
-
|
-
|
2
|
2
|
2
|
Capex / Sales
|
309.07%
|
125.5%
|
68.48%
|
-
|
-
|
20%
|
2.35%
|
0.81%
|
Announcement Date
|
26/02/20
|
25/02/21
|
23/02/22
|
03/02/23
|
22/02/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -32.62% | 1.4B | | +151.59% | 144M | | +18.94% | 124M | | +16.90% | 81.33M |
Biometric Products
|